Fredric L. Coe to Sodium Chloride Symporter Inhibitors
This is a "connection" page, showing publications Fredric L. Coe has written about Sodium Chloride Symporter Inhibitors.
Connection Strength
0.465
-
Safety of losartan in hypertensive patients with thiazide-induced hyperuricemia. Kidney Int. 1999 Nov; 56(5):1879-85.
Score: 0.169
-
Pathophysiology-based treatment of idiopathic calcium kidney stones. Clin J Am Soc Nephrol. 2011 Aug; 6(8):2083-92.
Score: 0.095
-
Prevention of kidney stones. Am J Med. 1981 Oct; 71(4):514-6.
Score: 0.048
-
Pathogenesis and treatment of calcium stones. Semin Nephrol. 1996 Sep; 16(5):398-411.
Score: 0.034
-
Calcium restriction, thiazide, citrate, and allopurinol in calcium oxalate nephrolithiasis. Acta Urol Belg. 1994 Jun; 62(2):25-9.
Score: 0.029
-
Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with time. Nephrol Dial Transplant. 2009 Jan; 24(1):130-6.
Score: 0.019
-
Pathophysiology of hypercalciuria. Am J Physiol. 1984 Jul; 247(1 Pt 2):F1-13.
Score: 0.015
-
Uric acid and calcium oxalate nephrolithiasis. Kidney Int. 1983 Sep; 24(3):392-403.
Score: 0.014
-
Idiopathic hypercalciuria in calcium nephrolithiasis. Dis Mon. 1980 Sep; 26(12):1-36.
Score: 0.011
-
Treatment of renal calculi. Adv Intern Med. 1980; 26:373-92.
Score: 0.011
-
Treatment of hypertension by computer and physician-a prospective controlled study. J Chronic Dis. 1977 Feb; 30(2):81-92.
Score: 0.009
-
Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis. N Engl J Med. 1974 Dec 19; 291(25):1344-50.
Score: 0.008
-
Factors that predict relapse of calcium nephrolithiasis during treatment: a prospective study. Am J Med. 1982 Jan; 72(1):17-24.
Score: 0.003